These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2844342)

  • 1. Prevention and treatment of cytomegalovirus infection after marrow transplantation.
    Meyers JD
    Bone Marrow Transplant; 1988 Mar; 3(2):95-104. PubMed ID: 2844342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of cytomegalovirus infection after marrow transplantation.
    Meyers JD
    Rev Infect Dis; 1989; 11 Suppl 7():S1691-705. PubMed ID: 2557664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prophylaxis of cytomegalovirus infection.
    Bowden RA; Meyers JD
    Semin Hematol; 1990 Apr; 27(2 Suppl 1):17-21; discussion 28-9. PubMed ID: 2160127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prevention and treatment of cytomegalovirus infections after graft of allogenic bone marrow].
    Gluckman E; McMazeron ; Keable H; Meletis J; Bombail D; Jolivet I; Huart JJ; Nebout T; Cavazzana M; De Castro H
    Nouv Rev Fr Hematol (1978); 1987; 29(1):17-21. PubMed ID: 3035485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention and treatment of cytomegalovirus infection and disease after bone marrow transplantation in the 1990s.
    Winston DJ; Gale RP
    Bone Marrow Transplant; 1991 Jul; 8(1):7-11. PubMed ID: 1655140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytomegalovirus infections after allogeneic bone marrow transplantation.
    Winston DJ; Ho WG; Champlin RE
    Rev Infect Dis; 1990; 12 Suppl 7():S776-92. PubMed ID: 2173107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strategies for the prevention of cytomegalovirus disease after marrow transplantation.
    Goodrich JM; Boeckh M; Bowden R
    Clin Infect Dis; 1994 Aug; 19(2):287-98. PubMed ID: 7986901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of human cytomegalovirus infection and disease after allogeneic bone marrow transplantation.
    Stocchi R; Ward KN; Fanin R; Baccarani M; Apperley JF
    Haematologica; 1999 Jan; 84(1):71-9. PubMed ID: 10091394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ganciclovir three times per week is not adequate to prevent cytomegalovirus reactivation after T cell-depleted marrow transplantation.
    Przepiorka D; Ippoliti C; Panina A; Goodrich J; Giralt S; van Besien K; Mehra R; Deisseroth AB; Andersson B; Luna M
    Bone Marrow Transplant; 1994 Apr; 13(4):461-4. PubMed ID: 8019472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Foscarnet for prevention of cytomegalovirus infection in allogeneic marrow transplant recipients unable to receive ganciclovir.
    Ippoliti C; Morgan A; Warkentin D; van Besien K; Mehra R; Khouri I; Giralt S; Gajewski J; Champlin R; Andersson B; Przepiorka D
    Bone Marrow Transplant; 1997 Sep; 20(6):491-5. PubMed ID: 9313883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized clinical trial of ganciclovir vs acyclovir for prevention of cytomegalovirus antigenemia after allogeneic transplantation.
    Burns LJ; Miller W; Kandaswamy C; DeFor TE; MacMillan ML; Van Burik JA; Weisdorf DJ
    Bone Marrow Transplant; 2002 Dec; 30(12):945-51. PubMed ID: 12476289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ganciclovir prophylaxis for cytomegalovirus infection in pediatric allogeneic bone marrow transplant recipients.
    Canpolat C; Culbert S; Gardner M; Whimbey E; Tarrand J; Chan KW
    Bone Marrow Transplant; 1996 Apr; 17(4):589-93. PubMed ID: 8722360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention and treatment of cytomegalovirus infection.
    Meyers JD
    Annu Rev Med; 1991; 42():179-87. PubMed ID: 1852147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progress in the prevention of cytomegalovirus infection after allogeneic bone marrow transplantation.
    Devergie A; Traineau R; Esperou-Bourdeau H; Ribaud P; Socié G; Richard P; Selimi F; Hirsch I; Gluckman E
    Nouv Rev Fr Hematol (1978); 1994; 36 Suppl 1():S89-90. PubMed ID: 8177726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of primary cytomegalovirus infection after allogeneic bone marrow transplantation by using leukocyte-poor random blood products from cytomegalovirus-unscreened blood-bank donors.
    De Witte T; Schattenberg A; Van Dijk BA; Galama J; Olthuis H; Van der Meer JW; Kunst VA
    Transplantation; 1990 Dec; 50(6):964-8. PubMed ID: 2175059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of cytomegalovirus infection.
    Meyers JD
    Am J Med; 1988 Aug; 85(2A):102-6. PubMed ID: 2841853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention and treatment of cytomegalovirus pneumonia in transplant recipients.
    Zaia JA
    Clin Infect Dis; 1993 Nov; 17 Suppl 2():S392-9. PubMed ID: 8274605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early treatment with ganciclovir to prevent cytomegalovirus disease after allogeneic bone marrow transplantation.
    Goodrich JM; Mori M; Gleaves CA; Du Mond C; Cays M; Ebeling DF; Buhles WC; DeArmond B; Meyers JD
    N Engl J Med; 1991 Dec; 325(23):1601-7. PubMed ID: 1658652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized comparison of oral valacyclovir and intravenous ganciclovir for prevention of cytomegalovirus disease after allogeneic bone marrow transplantation.
    Winston DJ; Yeager AM; Chandrasekar PH; Snydman DR; Petersen FB; Territo MC;
    Clin Infect Dis; 2003 Mar; 36(6):749-58. PubMed ID: 12627359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pilot phase II study of alternate day ganciclovir and foscarnet in preventing cytomegalovirus (CMV) infections in at-risk pediatric and adolescent allogeneic stem cell transplant recipients.
    Shereck EB; Cooney E; van de Ven C; Della-Lotta P; Cairo MS
    Pediatr Blood Cancer; 2007 Sep; 49(3):306-12. PubMed ID: 16972242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.